Argentina
| info:eu-repo/semantics/article
Antifungal activity of Zuccagnia punctata Cav.: Evidence for the mechanism of action
Fecha
2007-08Registro en:
Svetaz, Laura Andrea; Agüero, María Belén; Alvarez, Sandra; Luna, Lorena Celina; Feresin, Gabriela Egly; et al.; Antifungal activity of Zuccagnia punctata Cav.: Evidence for the mechanism of action; Georg Thieme Verlag Kg; Planta Medica; 73; 10; 8-2007; 1074-1080
0032-0943
CONICET Digital
CONICET
Autor
Svetaz, Laura Andrea
Agüero, María Belén
Alvarez, Sandra
Luna, Lorena Celina
Feresin, Gabriela Egly
Derita, Marcos Gabriel
Tapia, Alejandro
Zacchino, Susana Alicia Stella
Resumen
Petroleum ether and dichloromethane extracts of fruits, aerial parts and exudate of Zuccagnia punctata Cav. (Fabaceae) showed moderate antifungal activities against the yeasts C. albicans, S. cerevisiae and C. neoformans (MICs: 62.5-250 μg/mL) and very strong antifungal activities against the dermatophytes M. gypseum, T. rubrum and T. mentagrophytes (MICs: 8-16 μg/mL) thus supporting the ethnopharmacological use of this plant. Antifungal activity-directed fractionation of active extracts by using bioautography led to the isolation of 2′,4′-dihydroxy-3′-methoxychalcone (1) and 2′,4′-dihydroxychalcone (2) as the compounds responsible for the antifungal activity. Second-order studies included MIC80, MIC 50 and MFC of both chalcones in an extended panel of clinical isolates of the most sensitive fungi, and also comprised a series of targeted assays. They showed that the most active chalcone 2 is fungicidal rather than fungistatic, does not disrupt the fungal membranes up to 4 x MFC and does not act by inhibiting the fungal cell wall. So, 2′,4′-dihydroxychalcone would act by a different mechanism of action than the antifungal drugs in current clinical use, such as amphotericin B, azoles or echinocandins, and thus appears to be very promising as a novel antifungal agent. © Georg Thieme Verlag KG Stuttgart.